Oral mucosal lesions | Proportion with a specific lesion in the total group of patients (n = 544) | Proportion with a specific lesion in the total group of patients with any OML (n = 315) | Proportion with specific lesion within 14 OML groups | Biopsy |
---|---|---|---|---|
Tongue lesions | n (%) | % | % | |
Coated tongue | 61 (11.2) | 19.4 | 48.0 | |
Fissured tongue | 26 (4.8) | 8.3 | 20.5 | |
Geographic tongue | 23 (4.2) | 7.3 | 18.1 | 2(+ve)* |
Atrophy of tongue papillae | 17 (3.1) | 5.4 | 13.4 | 1(+ve) |
Geographic tongue+Fissured tongue | 12 (2.2) | 3.8 | 9.4 | |
Tongue-tie | 4 (0.7) | 1.3 | 3.1 | |
Total number of patients with any tongue lesion ¶ | 127 (23.3) | 40.3 | ||
White lesions | ||||
Snuff dipper's lesion | 30 (5.5) | 9.5 | 28.8 | 8(+ve) |
Frictional lesions | 25 (4.6) | 7.9 | 24.0 | 4(+ve) |
Leukoplakia | 17 (3.1) | 5.4 | 16.3 | 5(+ve) |
Vitiligo | 16 (2.9) | 5.1 | 15.4 | |
Nicotine stomatitis | 7 (1.3) | 2.2 | 6.7 | |
Lichen planus | 5 (0.9) | 1.6 | 4.8 | 3(+ve) |
Lupus erythematosus | 4 (0.7) | 1.3 | 3.8 | 1(-ve)§ |
Unspecified nicotine stomatitis | 3 (0.6) | 1.0 | 2.9 | |
Lichenoid lesions | 1 (0.2) | 0.3 | 1.0 | 1(+ve) |
Total number of patients with any white lesion ¶ | 104 (19.1) | 33.0 | ||
Red and blue lesions | ||||
Erythema | 29 (5.3) | 9.2 | 48.3 | 2(-ve) |
Petechia | 25 (4.6) | 7.9 | 41.7 | |
Erosion | 7 (1.3) | 2.2 | 11.7 | |
Hemangioma | 3 (0.6) | 1.0 | 5.0 | |
Total number of patients with any red and blue lesion ¶ | 60 (11) | 19.0 | 100 | |
Vesiculobullous diseases | ||||
Pemphigus vulgaris | 15(2.8) | 4.8 | 46.9 | 9(8+ve) |
Chickenpox | 8(1.5) | 2.5 | 25 | |
Bullous pemphigoid | 6(1.1) | 1.9 | 18.7 | 3(-ve) |
Herpes labialis | 2(0.4) | 0.6 | 6.2 | |
Vesiculobullous lesion (not verified) | 1(0.2) | 0.3 | 3.1 | |
Total number of patients with any vesiculobullous disease | 32 (6) | 10.2 | 100 | |
Ulcerative conditions | ||||
RAS | 16 (2.9) | 5.1 | 66.7 | 1(+ve) |
Drug reaction | 3 (0.6) | 1.0 | 12.5 | |
Stevens-Johonson syndrome | 2 (0.4) | 0.6 | 8.3 | |
Erythema multiforme | 1 (0.2) | 0.3 | 4.2 | |
Traumatic ulcer | 1 (0.2) | 0.3 | 4.2 | |
Unspecified ulcer | 1 (0.2) | 0.3 | 4.2 | |
Total number of patients with any ulcerative condition | 24 (4.5) | 7.6 | 100 | |
Pigmented Lesions | ||||
Melanotic macules | 20 (3.7) | 6.3 | 95 | 1(+ve) |
Gingival tattoo | 1 (0.2) | 0.3 | 4.8 | |
Total number of patients with any pigmented Lesion | 21 (3.9) | 6.7 | 100 | |
Connective tissue lesions | ||||
Fibroepithelial polyp | 9 (1.7) | 2.9 | 81.8 | 4(+ve) |
Denture induced fibrous hyperplasia | 2 (0.4) | 0.6 | 18.2 | |
Total number of patients with any connective tissue lesion | 11 (2.1) | 3.5 | 100 | |
Fungal infections | ||||
Acute erythematous candidiasis | 3 (0.6) | 1.0 | 30 | 1(-ve) |
Median rhomboid glossitis | 3 (0.6) | 1.0 | 30 | |
Pseodomembranous candidiasis | 3 (0.6) | 1.0 | 30 | |
Angular cheilitis | 2 (0.4) | 0.6 | 20 | |
Chronic hyperplastic candidiasis | 1 (0.2) | 0.3 | 10 | |
Total number of patients with any fungal infection ¶ | 10 (1.8) | 3.2 | 100 | |
Benign nonodontogenic tumors | ||||
Soft tumor like lesion | 4 (0.7) | 1.3 | 66.7 | 1(-ve) |
Exostosis | 1 (0.2) | 0.3 | 16.7 | |
Palatal tori | 1 (0.2) | 0.3 | 16.7 | |
Total number of patients with any benign nonodontogenic tumor | 6 (11) | 1.9 | 100 | |
Perioral lesions | ||||
Perioral dermatitis | 4 (0.7) | 1.3 | 80 | |
Perioral wart | 1 (0.2) | 0.3 | 20 | |
Total number of patients with any perioral lesion | 5 (0.9) | 1.6 | 100 | |
Lip lesions | ||||
Unspecified cheilitis | 2 (0.4) | 0.6 | 40 | |
Hypopigmented lips | 2 (0.4) | 0.6 | 40 | |
Cheilitis glandularis | 1 (0.2) | 0.3 | 20 | |
Total number of patients with any lip lesion | 5 (1.0) | 1.6 | 100 | |
Verrucal papillary lesions | ||||
Papillary hyperplasia | 3 (0.6) | 1.0 | 75 | 1(+ve) |
Focal epithelial hyperplasia | 1 (0.2) | 0.3 | 25 | |
Total number of patients with any verrucal papillary lesion | 4 (0.7) | 1.3 | 100 | |
Salivary gland diseases | ||||
Mucocele | 2 (0.4) | 0.6 | 100 | 2(+ve) |
Total number of patients with any salivary gland disease | 2 | |||
Malignant tumours | ||||
Kaposi sarcoma | 1 (0.2) | 0.3 | 100 | |
Total number of patients with any malignant tumour | 1 |